Entering text into the input field will update the search result below

Adamis Pharmaceuticals regains Nasdaq compliance

  • Adamis Pharmaceuticals (NASDAQ:ADMP) trade low, down 8%, despite regaining Nasdaq compliance.
  • The company had received the letter as it failed to file for quarterly reports, Form 10-Q for the periods ended March 31, 2021, June 30, 2021 and September 30, 2021.

Recommended For You

More Trending News

About DMKPQ Stock

SymbolLast Price% Chg
Market Cap
PE
Yield (TTM)
Rev Growth (YoY)
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
DMKPQ--
DMK Pharmaceuticals Corporation